The Australian study of HIV and injecting drug use. Part II: Predicting exposure to hepatitis C and hepatitis B

Drug and Alcohol Review

Volumn 16, Issue 3, 1997, Pages 215-220

  Carruthers, Susan J ^a   Loxley, Wendy M ^a   Phillips, Mike ^a   Bevan, Jude S ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Epidemiology; Hepatitis B; Hepatitis C; HIV AIDS; Injecting drug use

Indexed keywords

EID: 0031488787     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/09595239800187391     Document Type: Article

References (8)

1. Crofts N, Hopper J, Bowden S, Breschkin A, Milner R, Locarnini S. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust 1993;159:237-41.
2. Carruthers S, Loxley W. Hepatitis C and young drug users: are they about to join the epidemic? Aust J Public Health 1995;19:421-4.
3. Gust I. Control of hepatitis B in Australia. Med J Aust 1992;156:819-21.
4. Darke S. Injecting drug users and the human immunodeficiency virus: what do we know? Drug Alcohol Rev 1992;11:153-61.
5. Klee H, Faugier J, Hayes C, Morris J. Factors associated with risk behaviour among injecting drug users. AIDS Care 1990;2:133-45.
6. Ball J, Lange W, Myers C, Friedman S. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav 1988;29:214-16.
7. Loxley W, Carruthers S, Bevan J. In the same vein: first report of the Australian study of HIV and injecting drug use. Perth, ASHIDU, NCRPDA, Curtin University of Technology, 1995.
8. Strang J, Farrell M. The other virus: hepatitis explained. Druglink 1991;6:7-9.